---
title: "Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit | WHWK Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287060019.md"
description: "Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit | WHWK Stock News"
datetime: "2026-05-20T04:00:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287060019.md)
  - [en](https://longbridge.com/en/news/287060019.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287060019.md)
---

# Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit | WHWK Stock News

Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit | WHWK Stock News

### Related Stocks

- [WHWK.US](https://longbridge.com/en/quote/WHWK.US.md)
- [TD.US](https://longbridge.com/en/quote/TD.US.md)

## Related News & Research

- [Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum | WHWK Stock News](https://longbridge.com/en/news/286560823.md)
- [Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data](https://longbridge.com/en/news/286990060.md)
- [Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform | XBIO Stock News](https://longbridge.com/en/news/286257227.md)
- [‘Solve all diseases,’ you say?](https://longbridge.com/en/news/287121830.md)
- [Medtronic plans to buy SPR Therapeutics for $650 million to expand pain treatment options](https://longbridge.com/en/news/287081570.md)